½ÃÀ庸°í¼­
»óǰÄÚµå
1769676

¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå º¸°í¼­(2025³â)

Nocturnal Leg Cramps Treatment Global Market Report 2025

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµÉ ¿¹Á¤ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀå Àü¸ÁÀº ¿¹¹æ Ä¡·á¿¡ ´ëÇÑ °­Á¶, ±ÙÀ° ±â´É°ú °ü·ÃµÈ Áö¼ÓÀûÀÎ À¯Àü ¿¬±¸, ÀǾàǰ Àü´Þ ½Ã½ºÅÛÀÇ Çõ½Å, Àüü·ÐÀû °Ç°­ Á¢±Ù¹ý¿¡ ´ëÇÑ °ü½É Áõ°¡, Àå°ú ±ÙÀ°ÀÇ °ü·Ã¼º¿¡ ´ëÇÑ Áö½Ä Çâ»ó µî¿¡ ±âÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Áø´Ü ¹× ¸ÂÃãÇü Ä¡·á¿¡ AIÀÇ »ç¿ë, »ýü ÀüÀÚ ÀÇÇÐÀÇ °³¹ß, ±ÙÀ° ÀÚ±Ø ÀåÄ¡ÀÇ µµÀÔ, ¼ö¸é ¸ð´ÏÅ͸µ ±â¼úÀÇ ¹ßÀü, ·Îº¿ º¸Á¶ ¹°¸® Ä¡·áÀÇ Àû¿ë µîÀÌ ÀÖ½À´Ï´Ù.

³ëÀÎ Àα¸ÀÇ Áõ°¡´Â ¾ÕÀ¸·Î ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ëÀÎ Àα¸´Â ÀϹÝÀûÀ¸·Î 65¼¼ ÀÌ»óÀÇ °³ÀÎÀ» ÀǹÌÇÕ´Ï´Ù. ÀÌ Àα¸´Â ÀÇ·á ¼­ºñ½ºÀÇ °³¼±, ¿µ¾ç »óÅÂÀÇ Çâ»ó, À§»ý ½Ã¼³ÀÇ °³¼±, ÀÇÇÐÀÇ ¹ßÀü¿¡ µû¸¥ ±â´ë ¼ö¸íÀÇ Áõ°¡·Î ÀÎÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á´Â ÅëÁõÀ» ÁÙÀÌ°í ¼ö¸éÀÇ ÁúÀ» °³¼±Çϸç À̵¿¼ºÀ» Çâ»ó½ÃÄÑ ³ëÀÎÀÇ Àü¹ÝÀûÀÎ °Ç°­°ú µ¶¸³¼ºÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù¿¡ ¿µ±¹ Á¤ºÎ ºÎóÀÎ ±¹°¡Åë°èû(Office for National Statistics)ÀÌ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, 2022³â À×±Û·£µå¿Í ¿þÀϽº¿¡¼­ 90¼¼ ÀÌ»ó Àα¸´Â 55¸¸ 835¸íÀ¸·Î ±â·ÏÀûÀÎ ÃÖ°íÄ¡¸¦ ±â·ÏÇßÀ¸¸ç, ÀÌ´Â 2021³â ´ëºñ 2.1% Áõ°¡ÇÑ ¼öÄ¡ÀÔ´Ï´Ù. µû¶ó¼­ °í·É Àα¸ÀÇ Áõ°¡´Â ¾ß°£ ´Ù¸® °æ·Ã Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¾É¾Æ ÀÖ´Â »ýȰ ¹æ½ÄÀÇ Áõ°¡´Â ¾ÕÀ¸·Î ¾ß°£ ´Ù¸® °æ·Ã Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾É¾Æ ÀÖ´Â »ýȰ ¹æ½ÄÀ̶õ ½Åü Ȱµ¿ÀÌ °ÅÀÇ ¶Ç´Â ÀüÇô ¾ø´Â »ýȰ ¹æ½ÄÀ» ÀǹÌÇϸç, ÀϹÝÀûÀ¸·Î Àå½Ã°£ ¾É°Å³ª ´©¿ö ÀÖ´Â »óŰ¡ Áö¼ÓµÇ°í, ¿òÁ÷ÀÓÀ̳ª ¿îµ¿ÀÌ ÃÖ¼ÒÇÑÀ¸·Î Á¦ÇѵǴ °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. Á÷Àå, ¿À¶ô, Ä¿¹Â´ÏÄÉÀ̼ÇÀ» À§ÇÑ ½º¸¶Æ®Æù, ÄÄÇ»ÅÍ, TVÀÇ ±¤¹üÀ§ÇÑ »ç¿ëÀ¸·Î ÀÎÇÑ È­¸é ½Ãû ½Ã°£ÀÇ Áõ°¡·Î ÀÎÇØ ¾É¾ÆÀÖ´Â »ýȰ ½À°üÀÌ Áõ°¡Çϸ鼭 Àå½Ã°£ ¾É¾ÆÀÖ´Â °ÍÀÌ ÃËÁøµÇ°í ½Åü Ȱµ¿ÀÌ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á´Â Àå½Ã°£ÀÇ È°µ¿ ºÎÁ·À¸·Î ¾ÇÈ­µÉ ¼ö ÀÖ´Â ¹ã¿¡ ÀÚÁÖ ¹ß»ýÇÏ´Â °íÅ뽺·¯¿î ±ÙÀ° °æ·ÃÀ» ¿ÏÈ­ÇÏ°í ±ÙÀ° °Ç°­, À̵¿¼º ¹× ¼ö¸éÀÇ ÁúÀ» °³¼±ÇÏ¿© ¾É¾ÆÀÖ´Â »ýȰ ¹æ½ÄÀ» °¡Áø »ç¶÷µéÀ» Áö¿øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÁ¡Àº °³ÀÎÀÌ ´õ ±ÔÄ¢ÀûÀÎ ½Åü Ȱµ¿À» Çϵµ·Ï µ¿±â¸¦ ºÎ¿©ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ½ºÀ§½º¿¡ º»ºÎ¸¦ µÐ Á¤ºÎ °£ ±â±¸ÀÎ ¼¼°èº¸°Ç±â±¸(WHO)°¡ 2024³â 6¿ù¿¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, 2022³â¿¡ Àü ¼¼°è ¼ºÀÎÀÇ 31%ÀÎ ¾à 18¾ï ¸íÀÌ ±ÇÀå ½Åü Ȱµ¿ ¼öÁØÀ» ÃæÁ·ÇÏÁö ¸øÇßÀ¸¸ç, ÀÌ·¯ÇÑ µ¿ÇâÀÌ °è¼ÓµÉ °æ¿ì 2030³â¿¡´Â ºñȰµ¿ ºñÀ²ÀÌ 35%±îÁö Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª 19 ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á : PESTEL ºÐ¼®(Á¤Ä¡, »çȸ, ±â¼ú, ȯ°æ, ¹ýÀû ¿äÀÎ, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ)
  • ÃÖÁ¾ ÀÌ¿ë »ê¾÷ÀÇ ºÐ¼®
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : ¼ºÀå·ü ºÐ¼®
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå ½ÇÀû : ±Ô¸ð¿Í ¼ºÀå(2019-2024³â)
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå ¿¹Ãø : ±Ô¸ð¿Í ¼ºÀå(2024-2029³â, 2034³â)
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á : Àüü ½ÃÀå ±Ô¸ð(TAM)

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : Ä¡·á À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ÀǾàǰ
  • °¡Á¤ ¿ä¹ý
  • ¹°¸®Ä¡·á
  • ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È­
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : Åõ¿© °æ·Îº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • °æ±¸
  • ±¹¼Ò
  • Á¤¸Æ³»
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : ȯÀÚÀÇ Àα¸ Åë°èº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ³ëÀÎ
  • ¿îµ¿ ¼±¼ö
  • ÀÓ»êºÎ
  • ¸¸¼º ÁúȯÀÚ
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : À¯Åë ä³Îº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • ¿Â¶óÀÎ ¾à±¹
  • ±âŸ À¯Åë ä³Î
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ȨÄɾî
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : ÀǾàǰ À¯Çüº° ¼¼ºÐÈ­, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ±ÙÀ° ÀÌ¿ÏÁ¦
  • ¸¶±×³×½· º¸ÃæÁ¦
  • ºñŸ¹Î B º¸ÃæÁ¦
  • Ç×°æ·ÃÁ¦
  • ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦(NSAID)
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : °¡Á¤ ¿ä¹ý À¯Çüº° ¼¼ºÐÈ­, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¿¦¼Ø¼ÖÆ®¹ö½º
  • ¿Â½ÀÆ÷ ¶Ç´Â ³Ã½ÀÆ÷
  • ÀüÇØÁú ¿ë¾×¿¡ ÀÇÇÑ ¼öºÐ º¸±Þ
  • ½ºÆ®·¹Ä¡ ¿îµ¿
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : ¹°¸®Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ½ºÆ®·¹Äª°ú ±Ù·Â °­È­ ¿îµ¿
  • ¸¶»çÁö Ä¡·á¹ý
  • Å×ÀÌÇÎ Å×Å©´Ð
  • ±Ù¸· ÀÌ¿Ï
  • ¹°¸®Ä¡·á ¹æ¹ý
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È­ À¯Çüº° ¼¼ºÐÈ­, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ÀûÀýÇÑ ¼öºÐ º¸±Þ
  • ±ÕÇü ÀâÈù ½Ä»ç
  • Á¤±âÀûÀÎ ¿îµ¿
  • Àå½Ã°£ ¾É°Å³ª ¼­ ÀÖ´Â °ÍÀ» ÇÇÇϱâ
  • ¼ö¸é ÀÚ¼¼ ¹× ¹ß µé¾î¿Ã¸®±â
  • ÀûÀýÇÑ ½Å¹ß Âø¿ë

Á¦7Àå Áö¿ªº°, ±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : Áö¿ªº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¼¼°èÀÇ ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : ±¹°¡º°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : °æÀï ±¸µµ
  • ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå : ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Teva Pharmaceutical Industries Ltd. : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Mylan NV : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Astellas Pharma Inc. : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • DAIICHI SANKYO COMPANY, LIMITED : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Apotex Inc. : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

  • Sun Pharmaceutical Industries Limited
  • Hyland's Inc.
  • Swanson Health Products Inc.
  • Boiron USA
  • MAGNOX
  • Blackmores Limited
  • Ferring Pharmaceuticals
  • Solgar Inc.
  • Genexa Inc.
  • Naveh Pharma Ltd.
  • Hydratis
  • Crampeze
  • Monisha Mantra
  • Zydus Cadila
  • Flex Pharma Inc.

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

  • ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ±¹°¡
  • ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ºÎ¹®
  • ¾ß°£ ´Ù¸® °æ·Ã Ä¡·á ½ÃÀå(2029³â) : ¼ºÀå Àü·«
    • ½ÃÀå µ¿Çâ¿¡ ±âÃÊÇÑ Àü·«
    • °æÀï Àü·«

Á¦36Àå ºÎ·Ï

HBR 25.07.18

Nocturnal leg cramp treatment involves the management and alleviation of sudden, involuntary muscle contractions that typically affect the calf or foot during sleep. This treatment approach includes methods such as stretching exercises, proper hydration, and magnesium supplementation to ease discomfort and reduce the likelihood of recurring painful muscle spasms at night.

There are several main categories of nocturnal leg cramp treatments, including pharmaceuticals, home remedies, physical therapy, and lifestyle changes. Pharmaceuticals consist of medicinal drugs designed, produced, and administered to diagnose, treat, or prevent various health conditions. These medications can be taken through different routes such as oral, topical, and intravenous. The treatments cater to diverse patient groups including the elderly, athletes, pregnant women, and those with chronic health issues. They are made available through different distribution channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others, and are utilized by a range of end users including hospitals, specialty clinics, home care providers, and more.

The nocturnal leg cramps treatment market research report is one of a series of new reports from The Business Research Company that provides nocturnal leg cramps treatment market statistics, including nocturnal leg cramps treatment industry global market size, regional shares, competitors with a nocturnal leg cramps treatment market share, nocturnal leg cramps treatment market segments, market trends and opportunities, and any further data you may need to thrive in the nocturnal leg cramps treatment industry. This nocturnal leg cramps treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nocturnal leg cramps treatment market size has grown strongly in recent years. It will grow from $2.20 billion in 2024 to $2.35 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historical period was driven by increased awareness of electrolyte imbalances, advancements in physical therapy techniques, the effects of sedentary lifestyles, the rise in popularity of alternative medicine, and heightened public health consciousness.

The nocturnal leg cramps treatment market size is expected to see strong growth in the next few years. It will grow to $3.03 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The forecasted growth can be attributed to a greater emphasis on preventive care, ongoing genetic research related to muscle functionality, innovations in drug delivery systems, a growing interest in holistic health approaches, and enhanced knowledge of the gut-muscle connection. Prominent trends anticipated during the forecast period include the use of AI for diagnostics and customized treatments, the development of bioelectronic medicine, the introduction of muscle stimulation devices, advancements in sleep monitoring technologies, and the application of robotic-assisted physical therapy.

The growing geriatric population is expected to propel the growth of the nocturnal leg cramps treatment market going forward. The geriatric population refers to individuals who are typically aged 65 years and older. This population is increasing as life expectancy rises, driven by improved healthcare, better nutrition, enhanced sanitation, and medical advancements. Nocturnal leg cramp treatment helps the geriatric population by reducing pain, improving sleep quality, and enhancing mobility, all of which are essential for maintaining overall health and independence in older adults. For instance, in January 2024, according to the report published by the Office for National Statistics, a UK-based government department, in 2022, the population of individuals aged 90 and over in England and Wales reached a record high of 550,835, marking a 2.1% increase compared to 2021. Therefore, the growing geriatric population is driving growth in the nocturnal leg cramps treatment market.

The rise in sedentary lifestyles is expected to propel the growth of the nocturnal leg cramps treatment market going forward. A sedentary lifestyle refers to a way of living that involves little to no physical activity, typically characterized by prolonged periods of sitting or lying down, with minimal movement or exercise. The increase in sedentary habits due to greater screen time-driven by the widespread use of smartphones, computers, and televisions for work, entertainment, and communication-encourages prolonged sitting and reduces physical activity. Nocturnal leg cramp treatment supports individuals with sedentary lifestyles by relieving painful muscle spasms that often occur at night, which may be aggravated by prolonged inactivity, and encouraging improved muscle health, mobility, and sleep quality. These benefits can help motivate individuals to engage in more regular physical activity. For instance, in June 2024, according to a report published by the World Health Organization, a Switzerland-based intergovernmental organization, 31% of adults worldwide, or about 1.8 billion people, did not meet recommended physical activity levels in 2022, with inactivity rates projected to rise to 35% by 2030 if the trend continues. Therefore, the rise in sedentary lifestyles is driving growth in the nocturnal leg cramps treatment market.

Major companies operating in the nocturnal leg cramps treatment market are focusing on getting regulatory approvals for new drugs to expand market reach and improve patient outcomes. Regulatory approvals refer to the formal authorization granted by governmental or regulatory bodies for a drug, medical device, or treatment to be marketed and used by the public. For instance, in April 2023, Noctrix Health, a US-based medical equipment company, received FDA De Novo approval for its NTX100 Tonic Motor Activation (TOMAC) System to treat symptoms of moderate to severe restless legs syndrome (RLS) and improve sleep quality in patients who are refractory to medications. The system comprises two therapy units worn on the lower legs, delivering low-level electrical stimulation to the peroneal nerves, inducing tonic muscle activation to suppress RLS symptoms. Clinical trials, including the RESTFUL study, demonstrated significant improvements in RLS symptoms and sleep quality, with no severe adverse events reported.

Major players in the nocturnal leg cramps treatment market are Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., DAIICHI SANKYO COMPANY, LIMITED, Apotex Inc., Sun Pharmaceutical Industries Limited, Hyland's Inc., Swanson Health Products Inc., Boiron USA, MAGNOX, Blackmores Limited, Ferring Pharmaceuticals, Solgar Inc., Genexa Inc., Naveh Pharma Ltd., Hydratis, Crampeze, Monisha Mantra, Zydus Cadila, and Flex Pharma Inc.

North America was the largest region in the nocturnal leg cramps treatment market in 2024. The regions covered in nocturnal leg cramps treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nocturnal leg cramps treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nocturnal leg cramps treatment market consists of revenues earned by entities by providing services such as personalized therapy plans, over-the-counter medications, magnesium supplements, muscle relaxants, and physical therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The nocturnal leg cramps treatment market also includes sales of products including magnesium supplements, muscle relaxants, compression socks, topical creams, and heating pads. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nocturnal Leg Cramps Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nocturnal leg cramps treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nocturnal leg cramps treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nocturnal leg cramps treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment Type: Pharmaceuticals; Home Remedies; Physical Therapy; Lifestyle Modifications
  • 2) By Route Of Administration: Oral; Topical; Intravenous
  • 3) By Patient Demographics: Elderly; Athletes; Pregnant Women; Individuals With Chronic Conditions
  • 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
  • 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
  • Subsegments:
  • 1) By Pharmaceuticals: Muscle Relaxants; Magnesium Supplements; Vitamin B Supplements; Anticonvulsants; Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • 2) By Home Remedies: Epsom Salt Bath; Hot Or Cold Compress; Hydration With Electrolyte Solutions; Stretching Exercises
  • 3) By Physical Therapy: Stretching And Strengthening Exercises; Massage Therapy; Taping Techniques; Myofascial Release; Physical Therapy Modalities
  • 4) By Lifestyle Modifications: Proper Hydration; Balanced Diet; Regular Exercise; Avoiding Prolonged Sitting Or Standing; Sleep Position And Foot Elevation; Wearing Proper Footwear
  • Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Astellas Pharma Inc.; DAIICHI SANKYO COMPANY, LIMITED; Apotex Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nocturnal Leg Cramps Treatment Market Characteristics

3. Nocturnal Leg Cramps Treatment Market Trends And Strategies

4. Nocturnal Leg Cramps Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Nocturnal Leg Cramps Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Nocturnal Leg Cramps Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Nocturnal Leg Cramps Treatment Market Growth Rate Analysis
  • 5.4. Global Nocturnal Leg Cramps Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Nocturnal Leg Cramps Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Nocturnal Leg Cramps Treatment Total Addressable Market (TAM)

6. Nocturnal Leg Cramps Treatment Market Segmentation

  • 6.1. Global Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceuticals
  • Home Remedies
  • Physical Therapy
  • Lifestyle Modifications
  • 6.2. Global Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Topical
  • Intravenous
  • 6.3. Global Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Elderly
  • Athletes
  • Pregnant Women
  • Individuals With Chronic Conditions
  • 6.4. Global Nocturnal Leg Cramps Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Other Distribution Channels
  • 6.5. Global Nocturnal Leg Cramps Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End-Users
  • 6.6. Global Nocturnal Leg Cramps Treatment Market, Sub-Segmentation Of Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Muscle Relaxants
  • Magnesium Supplements
  • Vitamin B Supplements
  • Anticonvulsants
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • 6.7. Global Nocturnal Leg Cramps Treatment Market, Sub-Segmentation Of Home Remedies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Epsom Salt Bath
  • Hot Or Cold Compress
  • Hydration With Electrolyte Solutions
  • Stretching Exercises
  • 6.8. Global Nocturnal Leg Cramps Treatment Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stretching And Strengthening Exercises
  • Massage Therapy
  • Taping Techniques
  • Myofascial Release
  • Physical Therapy Modalities
  • 6.9. Global Nocturnal Leg Cramps Treatment Market, Sub-Segmentation Of Lifestyle Modifications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proper Hydration
  • Balanced Diet
  • Regular Exercise
  • Avoiding Prolonged Sitting Or Standing
  • Sleep Position And Foot Elevation
  • Wearing Proper Footwear

7. Nocturnal Leg Cramps Treatment Market Regional And Country Analysis

  • 7.1. Global Nocturnal Leg Cramps Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Nocturnal Leg Cramps Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nocturnal Leg Cramps Treatment Market

  • 8.1. Asia-Pacific Nocturnal Leg Cramps Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nocturnal Leg Cramps Treatment Market

  • 9.1. China Nocturnal Leg Cramps Treatment Market Overview
  • 9.2. China Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nocturnal Leg Cramps Treatment Market

  • 10.1. India Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nocturnal Leg Cramps Treatment Market

  • 11.1. Japan Nocturnal Leg Cramps Treatment Market Overview
  • 11.2. Japan Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nocturnal Leg Cramps Treatment Market

  • 12.1. Australia Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nocturnal Leg Cramps Treatment Market

  • 13.1. Indonesia Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nocturnal Leg Cramps Treatment Market

  • 14.1. South Korea Nocturnal Leg Cramps Treatment Market Overview
  • 14.2. South Korea Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nocturnal Leg Cramps Treatment Market

  • 15.1. Western Europe Nocturnal Leg Cramps Treatment Market Overview
  • 15.2. Western Europe Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nocturnal Leg Cramps Treatment Market

  • 16.1. UK Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nocturnal Leg Cramps Treatment Market

  • 17.1. Germany Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nocturnal Leg Cramps Treatment Market

  • 18.1. France Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nocturnal Leg Cramps Treatment Market

  • 19.1. Italy Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nocturnal Leg Cramps Treatment Market

  • 20.1. Spain Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nocturnal Leg Cramps Treatment Market

  • 21.1. Eastern Europe Nocturnal Leg Cramps Treatment Market Overview
  • 21.2. Eastern Europe Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nocturnal Leg Cramps Treatment Market

  • 22.1. Russia Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nocturnal Leg Cramps Treatment Market

  • 23.1. North America Nocturnal Leg Cramps Treatment Market Overview
  • 23.2. North America Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nocturnal Leg Cramps Treatment Market

  • 24.1. USA Nocturnal Leg Cramps Treatment Market Overview
  • 24.2. USA Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nocturnal Leg Cramps Treatment Market

  • 25.1. Canada Nocturnal Leg Cramps Treatment Market Overview
  • 25.2. Canada Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nocturnal Leg Cramps Treatment Market

  • 26.1. South America Nocturnal Leg Cramps Treatment Market Overview
  • 26.2. South America Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nocturnal Leg Cramps Treatment Market

  • 27.1. Brazil Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nocturnal Leg Cramps Treatment Market

  • 28.1. Middle East Nocturnal Leg Cramps Treatment Market Overview
  • 28.2. Middle East Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nocturnal Leg Cramps Treatment Market

  • 29.1. Africa Nocturnal Leg Cramps Treatment Market Overview
  • 29.2. Africa Nocturnal Leg Cramps Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Nocturnal Leg Cramps Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Nocturnal Leg Cramps Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nocturnal Leg Cramps Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Nocturnal Leg Cramps Treatment Market Competitive Landscape
  • 30.2. Nocturnal Leg Cramps Treatment Market Company Profiles
    • 30.2.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. DAIICHI SANKYO COMPANY, LIMITED Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Nocturnal Leg Cramps Treatment Market Other Major And Innovative Companies

  • 31.1. Sun Pharmaceutical Industries Limited
  • 31.2. Hyland's Inc.
  • 31.3. Swanson Health Products Inc.
  • 31.4. Boiron USA
  • 31.5. MAGNOX
  • 31.6. Blackmores Limited
  • 31.7. Ferring Pharmaceuticals
  • 31.8. Solgar Inc.
  • 31.9. Genexa Inc.
  • 31.10. Naveh Pharma Ltd.
  • 31.11. Hydratis
  • 31.12. Crampeze
  • 31.13. Monisha Mantra
  • 31.14. Zydus Cadila
  • 31.15. Flex Pharma Inc.

32. Global Nocturnal Leg Cramps Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nocturnal Leg Cramps Treatment Market

34. Recent Developments In The Nocturnal Leg Cramps Treatment Market

35. Nocturnal Leg Cramps Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Nocturnal Leg Cramps Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Nocturnal Leg Cramps Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Nocturnal Leg Cramps Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦